We are live on
!
Find out more
Aviva Portfolio holdings
AUM
$59.6B
1-Year Est. Return
28.44%
This Fund
S&P 500
This Quarter
Est. Return
-1.85%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$59.6B
AUM Growth
+$306M
(+0.52%)
Cap. Flow
+$3.25B
Cap. Flow
% of AUM
5.45%
Top 10 Holdings %
Top 10 Hldgs %
34.29%
Holding
910
New
50
Increased
586
Reduced
175
Closed
66
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$2.14B |
| 2 |
SUNB
Sunbelt Rentals Holdings
SUNB
|
+$96.9M |
| 3 |
NVIDIA
NVDA
|
+$86.8M |
| 4 |
Microsoft
MSFT
|
+$86.3M |
| 5 |
Coca-Cola
KO
|
+$75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dominion Energy
D
|
+$90.4M |
| 2 |
CRH
CRH
|
+$79.8M |
| 3 |
Moody's
MCO
|
+$63.3M |
| 4 |
Procter & Gamble
PG
|
+$61.9M |
| 5 |
TSMC
TSM
|
+$56.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.72% |
| 2 | Financials | 12.76% |
| 3 | Healthcare | 12.55% |
| 4 | Communication Services | 9.75% |
| 5 | Consumer Discretionary | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Corcept Therapeutics
CORT
$9.83B
| – | – |
-6,045
| Closed | -$210K |
|
852
Crane Co
CR
$12.6B
| – | – |
-2,671
| Closed | -$493K |
|
|
CSW
853
CSW Industrials
CSW
$4.48B
| – | – |
-1,725
| Closed | -$506K |
|
854
Consolidated Water Co
CWCO
$464M
| – | – |
-14,055
| Closed | -$496K |
|
855
DHT Holdings
DHT
$2.88B
| – | – |
-37,593
| Closed | -$459K |
|
856
DNOW Inc
DNOW
$2.55B
| – | – |
-35,907
| Closed | -$476K |
|
857
Dynatrace
DT
$13B
| – | – |
-251,048
| Closed | -$10.9M |
|
858
Enerpac Tool Group
EPAC
$1.74B
| – | – |
-8,592
| Closed | -$329K |
|
859
F&G Annuities & Life
FG
$4.08B
| – | – |
-12,560
| Closed | -$387K |
|
860
Federal Signal
FSS
$6.96B
| – | – |
-4,449
| Closed | -$483K |
|
861
Genpact
G
$5.19B
| – | – |
-13,194
| Closed | -$617K |
|
862
Globus Medical
GMED
$10.3B
| – | – |
-5,693
| Closed | -$497K |
|
863
Halozyme
HALO
$9.14B
| – | – |
-11,674
| Closed | -$786K |
|
|
HDSN
864
Hudson Technologies
HDSN
$257M
| – | – |
-67,703
| Closed | -$464K |
|
865
Home BancShares
HOMB
$6.09B
| – | – |
-21,297
| Closed | -$592K |
|
866
ICICI Bank
IBN
$107B
| – | – |
-93,554
| Closed | -$2.79M |
|
867
JD.com
JD
$41.3B
| – | – |
-99,664
| Closed | -$2.86M |
|
868
Kforce
KFRC
$1.03B
| – | – |
-11,133
| Closed | -$344K |
|
869
Kingstone Companies
KINS
$292M
| – | – |
-11,158
| Closed | -$188K |
|
870
Stride
LRN
$3.64B
| – | – |
-7,575
| Closed | -$492K |
|
871
Macy's
M
$6.13B
| – | – |
-25,768
| Closed | -$568K |
|
872
Magnolia Oil & Gas
MGY
$4.72B
| – | – |
-21,447
| Closed | -$469K |
|
873
Mueller Industries
MLI
$13B
| – | – |
-11,524
| Closed | -$661K |
|
874
Molina Healthcare
MOH
$12B
| – | – |
-1,935
| Closed | -$336K |
|
875
NewMarket
NEU
$7.17B
| – | – |
-1,494
| Closed | -$1.03M |
|
Similar funds
QCM
NAMI
Aviva's Q1 2026 Portfolio in Review
As of Q1 2026, Aviva held 910 positions worth $59.6B, up 0.52% from $59.3B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Aviva deployed $3.25B of net new capital in Q1 2026, opening 50 new positions and adding to 586 existing holdings. Its largest new stake was AstraZeneca: 11,087,661 shares worth $2.15B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Dominion Energy, an estimated $90.4M trimmed.
- Aviva's largest Q1 2026 buy was AstraZeneca: 11,087,661 shares worth $2.15B.
- Aviva added most to NVIDIA in Q1 2026, an estimated $86.8M increase.
- Aviva's biggest Q1 2026 reduction was Dominion Energy, cutting an estimated $90.4M.
- Aviva fully exited Alibaba in Q1 2026, selling an estimated $51M.
- Aviva's ten largest holdings make up 34% of its $59.6B portfolio in Q1 2026.
- Aviva opened 50 new positions and closed 66 in Q1 2026.
- Aviva's portfolio value rose 0.52% quarter-over-quarter to $59.6B.
Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.